A comprehensive review and update on ulcerative colitis,
Tóm tắt
Từ khóa
Tài liệu tham khảo
Silverberg, 2005, Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology, Can J Gastroenterol, 19, 5A, 10.1155/2005/269076
Halling, 2017, Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases, World J Gastroenterol, 23, 6137, 10.3748/wjg.v23.i33.6137
Das, 2008, Is IBD an autoimmune disorder?, Inflamm Bowel Dis, 14, S97, 10.1097/00054725-200810001-00049
Cohen, 2010, Systematic review: the costs of ulcerative colitis in Western countries, Aliment Pharmacol Ther, 31, 693, 10.1111/j.1365-2036.2010.04234.x
Wilks, 1859, Morbid appearances in the intestines of Miss Bankes, Lond Med Gaz, 2, 264
Morita, 1995, Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991, J Gastroenterol, 30, 1
Subasinghe, 2011, Disease characteristics of inflammatory bowel disease (IBD), J Gastrointest Surg, 15, 1562, 10.1007/s11605-011-1588-5
Probert, 1992, Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire, Gut, 33, 687, 10.1136/gut.33.5.687
Carr, 1999, The effects of migration on ulcerative colitis: a three-year prospective study among Europeans and first- and second-generation South Asians in Leicester (1991-1994), Am J Gastroenterol, 94, 2918, 10.1111/j.1572-0241.1999.01438.x
Loftus, 2004, Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences, Gastroenterology, 126, 1504, 10.1053/j.gastro.2004.01.063
Shivashankar, 2017, Incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010, Clin Gastroenterol Hepatol, 15, 857, 10.1016/j.cgh.2016.10.039
Loftus, 2007, Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000, Inflamm Bowel Dis, 13, 254, 10.1002/ibd.20029
Bernstein, 1999, Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study, Am J Epidemiol, 149, 916, 10.1093/oxfordjournals.aje.a009735
Langholz, 1991, Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987, Scand J Gastroenterol, 26, 1247, 10.3109/00365529108998621
Higuchi, 2012, A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women, Am J Gastroenterol, 107, 1399, 10.1038/ajg.2012.196
Kappelman, 2007, The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States, Clin Gastroenterol Hepatol, 5, 1424, 10.1016/j.cgh.2007.07.012
Malik, 2015, Inflammatory bowel disease: historical perspective, epidemiology, and risk factors, Surg Clin North Am, 95, 1105, 10.1016/j.suc.2015.07.006
Karban, 2004, NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic jews with Crohn's disease, Am J Gastroenterol, 99, 1134, 10.1111/j.1572-0241.2004.04156.x
Veluswamy, 2010, African-American inflammatory bowel disease in a Southern U.S. health center, BMC Gastroenterol, 10, 104, 10.1186/1471-230X-10-104
Yang, 1993, Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews, Gut, 34, 517, 10.1136/gut.34.4.517
Halme, 2006, Family and twin studies in inflammatory bowel disease, World J Gastroenterol, 12, 3668, 10.3748/wjg.v12.i23.3668
Kopylov, 2016, Genetic predictors of benign course of ulcerative colitis—a North American inflammatory bowel disease genetics consortium study, Inflamm Bowel Dis, 22, 2311, 10.1097/MIB.0000000000000913
Harries, 1982, Non-smoking: a feature of ulcerative colitis, Br Med J, 284, 706, 10.1136/bmj.284.6317.706
Mahid, 2006, Smoking and inflammatory bowel disease: a meta-analysis, Mayo Clin Proc, 81, 1462, 10.4065/81.11.1462
Gajendran, 2018, A comprehensive review and update on Crohn's disease, Dis Mon, 64, 20, 10.1016/j.disamonth.2017.07.001
Cosnes, 2004, Gender differences in the response of colitis to smoking, Clin Gastroenterol Hepatol, 2, 41, 10.1016/S1542-3565(03)00290-8
Lakatos, 2007, Smoking in inflammatory bowel diseases: good, bad or ugly?, World J Gastroenterol, 13, 6134, 10.3748/wjg.v13.i46.6134
Biedermann, 2014, Smoking Cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH, Inflamm Bowel Dis, 20, 1496, 10.1097/MIB.0000000000000129
Persson, 1993, Use of oral moist snuff and inflammatory bowel disease, Int J Epidemiol, 22, 1101, 10.1093/ije/22.6.1101
Martini, 1976, Increased consumption of refined carbohydrates in patients with Crohn's disease, Klin Wochenschr, 54, 367, 10.1007/BF01469792
Glassman, 1990, Cow's milk protein sensitivity during infancy in patients with inflammatory bowel disease, Am J Gastroenterol, 85, 838
Geerling, 2000, Diet as a risk factor for the development of ulcerative colitis, Am J Gastroenterol, 95, 1008, 10.1111/j.1572-0241.2000.01942.x
Lepage, 2011, Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis, Gastroenterology, 141, 227, 10.1053/j.gastro.2011.04.011
Norman, 2015, Disease-specific alterations in the enteric virome in inflammatory bowel disease, Cell, 160, 447, 10.1016/j.cell.2015.01.002
Andersson, 2001, Appendectomy and protection against ulcerative colitis, New Engl J Med, 344, 808, 10.1056/NEJM200103153441104
Andersson, 2003, Appendectomy is followed by increased risk of Crohn's disease, Gastroenterology, 124, 40, 10.1053/gast.2003.50021
Gardenbroek, 2012, The effect of appendectomy on the course of ulcerative colitis: a systematic review, Colorectal Dis, 14, 545, 10.1111/j.1463-1318.2011.02600.x
Radford-Smith, 2008, What is the importance of appendectomy in the natural history of IBD?, Inflamm Bowel Dis, 14, S72, 10.1002/ibd.20623
Radford-Smith, 2002, Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease, Gut, 51, 808, 10.1136/gut.51.6.808
Rao, 1988, Symptoms and stool patterns in patients with ulcerative colitis, Gut, 29, 342, 10.1136/gut.29.3.342
Ford, 2015, Lack of utility of symptoms and signs at first presentation as predictors of inflammatory bowel disease in secondary care, Am J Gastroenterol, 110, 716, 10.1038/ajg.2015.117
Fumery, 2018, Natural history of adult ulcerative colitis in population-based cohorts: a systematic review, Clin Gastroenterol Hepatol, 16, 10.1016/j.cgh.2017.06.016
Conrad, 2014, Diagnosis and classification of ulcerative colitis, Autoimmun Rev, 13, 463, 10.1016/j.autrev.2014.01.028
Nikolaus, 2007, Diagnostics of inflammatory bowel disease, Gastroenterology, 133, 1670, 10.1053/j.gastro.2007.09.001
DeRoche, 2014, Histological evaluation in ulcerative colitis, Gastroenterol Rep, 2, 178, 10.1093/gastro/gou031
Magalhaes-Costa, 2014, Focal enhanced gastritis and macrophage microaggregates in the gastric mucosa: potential role in the differential diagnosis between Crohn's disease and ulcerative colitis, Arq Gastroenterol, 51, 276, 10.1590/S0004-28032014000400003
Parente, 2000, Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role, Am J Gastroenterol, 95, 705, 10.1111/j.1572-0241.2000.01851.x
Chang, 2004, Medical management of severe ulcerative colitis, Gastroenterol Clin North Am, 33, 235, 10.1016/j.gtc.2004.02.005
Gan, 2003, A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management, Am J Gastroenterol, 98, 2363, 10.1111/j.1572-0241.2003.07696.x
Issa, 2008, Clostridium difficile and inflammatory bowel disease, Inflamm Bowel Dis, 14, 1432, 10.1002/ibd.20500
Chen, 2017, Increased subsequent risk of inflammatory bowel disease association in patients with chronic pancreatitis: a nationwide population-based cohort study, Curr Med Res Opin, 33, 1077, 10.1080/03007995.2017.1300143
Nizam, 2000, Initial presentation of ulcerative colitis with acute pancreatitis, Am J Gastroenterol, 95, 825, 10.1111/j.1572-0241.2000.01892.x
Park, 2013, The characteristics of ulcerative colitis associated with autoimmune pancreatitis, J Clin Gastroenterol, 47, 520, 10.1097/MCG.0b013e31827fd4a2
Ravi, 2009, Inflammatory bowel disease in the setting of autoimmune pancreatitis, Inflamm Bowel Dis, 15, 1326, 10.1002/ibd.20898
Schafer, 2001, Acute pancreatitis as the first presentation of ulcerative colitis, J Clin Gastroenterol, 33, 86, 10.1097/00004836-200107000-00024
Gizard, 2014, Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease, Aliment Pharmacol Ther, 40, 3, 10.1111/apt.12794
Parente, 2007, Incidence and risk factors for gallstones in patients with inflammatory bowel disease: a large case-control study, Hepatology, 45, 1267, 10.1002/hep.21537
Marlow, 2013, Why interleukin-10 supplementation does not work in Crohn's disease patients, World J Gastroenterol, 19, 3931, 10.3748/wjg.v19.i25.3931
Danese, 2005, Extraintestinal manifestations in inflammatory bowel disease, World J Gastroenterol, 11, 7227, 10.3748/wjg.v11.i46.7227
Karmiris, 2016, Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease, J Crohns Ccolitis, 10, 429, 10.1093/ecco-jcc/jjv232
Vavricka, 2015, Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the swiss inflammatory bowel disease cohort, Inflamm Bowel Dis, 21, 1794, 10.1097/MIB.0000000000000429
Brown, 2015, Extraintestinal manifestations associated with inflammatory bowel disease, Surg Clin North Am, 95, 1245, 10.1016/j.suc.2015.08.002
Voulgari, 2011, Rheumatological manifestations in inflammatory bowel disease, Annals of gastroenterology, 24, 173
Malaty, 2017, Characterization and prevalence of spondyloarthritis and peripheral arthritis among patients with inflammatory bowel disease, Clin Exp Gastroenterol, 10, 259, 10.2147/CEG.S136383
Rodriguez-Reyna, 2009, Rheumatic manifestations of inflammatory bowel disease, World J Gastroenterol, 15, 5517, 10.3748/wjg.15.5517
Timani, 2008, Skin manifestations of inflammatory bowel disease, Clin Dermatol, 26, 265, 10.1016/j.clindermatol.2007.10.018
Singh, 2014, Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis, Clin Gastroenterol Hepatol, 12, 210, 10.1016/j.cgh.2013.04.033
Taleban, 2016, Ocular manifestations in inflammatory bowel disease are associated with other extra-intestinal manifestations, gender, and genes implicated in other immune-related traits, J Crohns Colitis, 10, 43, 10.1093/ecco-jcc/jjv178
Ganji-Arjenaki, 2017, Nephrolithiasis as a common urinary system manifestation of inflammatory bowel diseases: a clinical review and meta-analysis, J Nephropathol, 6, 264, 10.15171/jnp.2017.42
Oikonomou, 2011, Renal manifestations and complications of inflammatory bowel disease, Inflamm Bowel Dis, 17, 1034, 10.1002/ibd.21468
Storch, 2003, Pulmonary manifestations of inflammatory bowel disease, Inflamm Bowel Dis, 9, 104, 10.1097/00054725-200303000-00004
Ji, 2016, Alterations of pulmonary function in patients with inflammatory bowel diseases, Ann Thorac Med, 11, 249, 10.4103/1817-1737.191877
Giannotta, 2015, Thrombosis in inflammatory bowel diseases: what's the link?, Thrombosis J, 13, 14, 10.1186/s12959-015-0044-2
Grip, 2000, Inflammatory bowel disease promotes venous thrombosis earlier in life, Scand J Gastroenterol, 35, 619, 10.1080/003655200750023589
Miehsler, 2004, Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?, Gut, 53, 542, 10.1136/gut.2003.025411
Singh, 2014, Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis, Clin Gastroenterol Hepatol, 12
Zezos, 2014, Inflammatory bowel disease and thromboembolism, World J Gastroenterol, 20, 13863, 10.3748/wjg.v20.i38.13863
Chang, 2018, Intestinal and extraintestinal cancers associated with inflammatory bowel disease, Clin Colorectal Cancer, 17, e29, 10.1016/j.clcc.2017.06.009
Cosnes, 2011, Epidemiology and natural history of inflammatory bowel diseases, Gastroenterology, 140, 1785, 10.1053/j.gastro.2011.01.055
Charpentier, 2014, Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study, Gut, 63, 423, 10.1136/gutjnl-2012-303864
Stepaniuk, 2015, Characterization of inflammatory bowel disease in elderly patients: a review of epidemiology, current practices and outcomes of current management strategies, Can J Gastroenterol Hepatol, 29, 327, 10.1155/2015/136960
Mendoza Ladd, 2016, Demographic and clinical characteristics of a predominantly Hispanic population with inflammatory bowel disease on the US-Mexico border, South Med J, 109, 792
Nguyen, 2006, Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort, Am J Gastroenterol, 101, 1012, 10.1111/j.1572-0241.2006.00504.x
Damas, 2013, Phenotypic manifestations of inflammatory bowel disease differ between Hispanics and non-Hispanic whites: results of a large cohort study, Am J Gastroenterol, 108, 231, 10.1038/ajg.2012.393
Nguyen, 2006, Racial and geographic variations in colectomy rates among hospitalized ulcerative colitis patients, Clin Gastroenterol Hepatol, 4, 1507, 10.1016/j.cgh.2006.09.026
Moore, 2012, Comparison of the natural history of ulcerative colitis in African Americans and non-Hispanic Caucasians: a historical cohort study, Inflamm Bowel Dis, 18, 743, 10.1002/ibd.21796
Hou, 2009, Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review, Am J Gastroenterol, 104, 2100, 10.1038/ajg.2009.190
Gajendran, 2016, Analysis of hospital-based emergency department visits for inflammatory bowel disease in the USA, Dig Dis Sci, 61, 389, 10.1007/s10620-015-3895-2
Liverani, 2016, How to predict clinical relapse in inflammatory bowel disease patients, World J Gastroenterol, 22, 1017, 10.3748/wjg.v22.i3.1017
Walsh, 2017, Clinical predictors and natural history of disease extension in patients with ulcerative proctitis, Inflamm Bowel Dis, 23, 2035, 10.1097/MIB.0000000000001214
Patil, 2016, Role of histologic inflammation in the natural history of ulcerative colitis, Gastrointest Endosc Clin North Am, 26, 629, 10.1016/j.giec.2016.06.009
Gajendran, 2018, A comprehensive review and update on Crohn's disease, Dis Mon, 64, 20, 10.1016/j.disamonth.2017.07.001
Ho, 2004, Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second‐line medical therapy or surgery, Aliment Pharmacol Ther, 19, 1079, 10.1111/j.1365-2036.2004.01945.x
Sandborn, 2001, Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease, Inflamm Bowel Dis, 7, 192, 10.1097/00054725-200108000-00003
Koutroubakis, 2001, Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease, Am J Gastroenterol, 96, 449
Linskens, 2002, Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods, Eur J Gastroenterol Hepatol, 14, 1013, 10.1097/00042737-200209000-00013
Costa, 2005, Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease, Gut, 54, 364, 10.1136/gut.2004.043406
Van Assche, 2010, The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis, J Crohns Colitis, 4, 7, 10.1016/j.crohns.2009.12.003
Corte, 2015, Association between the ulcerative colitis endoscopic index of severity (UCEIS) and outcomes in acute severe ulcerative colitis, J Crohns Colitis, 9, 376, 10.1093/ecco-jcc/jjv047
de Lange, 2004, Inter-observer agreement in the assessment of endoscopic findings in ulcerative colitis, BMC Gastroenterol, 4, 9, 10.1186/1471-230X-4-9
Park, 2014, Appendiceal skip inflammation and ulcerative colitis, Dig Dis Sci, 59, 2050, 10.1007/s10620-014-3129-z
Rubin, 2010, The peri-appendiceal red patch in ulcerative colitis: review of the University of Chicago experience, Dig Dis Sci, 55, 3495, 10.1007/s10620-010-1424-x
Simpson, 2008, Endoscopic evaluation of patients with inflammatory bowel disease, Inflamm Bowel Dis, 14, 1287, 10.1002/ibd.20398
Annese, 2013, European evidence based consensus for endoscopy in inflammatory bowel disease, J Crohns Colitis, 7, 982, 10.1016/j.crohns.2013.09.016
Bitton, 2001, Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis, Gastroenterology, 120, 13, 10.1053/gast.2001.20912
Magro, 2013, European consensus on the histopathology of inflammatory bowel disease, J Crohns Colitis, 7, 827, 10.1016/j.crohns.2013.06.001
Kiesslich, 2017, Advanced endoscopy imaging in inflammatory bowel diseases, Gastrointest Endosc, 85, 496, 10.1016/j.gie.2016.10.034
Rex, 2017, Colorectal cancer screening: recommendations for physicians and patients from the U.S. multi-society task force on colorectal cancer, Am J Gastroenterol, 112, 1016, 10.1038/ajg.2017.174
Eaden, 2001, The risk of colorectal cancer in ulcerative colitis: a meta-analysis, Gut, 48, 526, 10.1136/gut.48.4.526
Guagnozzi, 2012, Colorectal cancer surveillance in patients with inflammatory bowel disease: what is new?, World J Gastrointest Endosc, 4, 108, 10.4253/wjge.v4.i4.108
Soetikno, 2002, Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis, Gastrointest Endosc, 56, 48, 10.1067/mge.2002.125367
Laine, 2015, SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease, Gastroenterology, 148, 10.1053/j.gastro.2015.01.031
Mattar, 2011, Current management of inflammatory bowel disease and colorectal cancer, Gastrointest Cancer Res, 4, 53
Levin, 2008, Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology, Gastroenterology, 134, 1570, 10.1053/j.gastro.2008.02.002
Rossi, 2016, Primary sclerosing cholangitis associated with inflammatory bowel disease: an update, Eur J Gastroenterol Hepatol, 28, 123, 10.1097/MEG.0000000000000532
Farraye, 2010, AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease, Gastroenterology, 138, 738, 10.1053/j.gastro.2009.12.037
Leighton, 2006, ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease, Gastrointest Endosc, 63, 558, 10.1016/j.gie.2006.02.005
Itzkowitz, 2005, Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease, Inflamm Bowel Dis, 11, 314, 10.1097/01.MIB.0000160811.76729.d5
Van Assche, 2013, Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations, J Crohns Colitis, 7, 1, 10.1016/j.crohns.2012.09.005
Farraye, 2006, Chromoendoscopy: a new vision for colonoscopic surveillance in IBD, Gastroenterology, 131, 323, 10.1053/j.gastro.2006.04.059
Ignjatovic, 2012, Narrow band imaging for detection of dysplasia in colitis: a randomized controlled trial, Am J Gastroenterol, 107, 885, 10.1038/ajg.2012.67
Laine, 2015, SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease, Gastrointest Endosc, 81, 10.1016/j.gie.2014.12.009
Fireman, 2003, Diagnosing small bowel Crohn's disease with wireless capsule endoscopy, Gut, 52, 390, 10.1136/gut.52.3.390
Eliakim, 2013, Video capsule endoscopy of the small bowel, Curr Opin Gastroenterol, 29, 133, 10.1097/MOG.0b013e32835bdc03
Adler, 2011, PillCam COLON capsule endoscopy: recent advances and new insights, Ther Adv Gastroenterol, 4, 265, 10.1177/1756283X11401645
Sung, 2012, The use of Pillcam Colon in assessing mucosal inflammation in ulcerative colitis: a multicenter study, Endoscopy, 44, 754, 10.1055/s-0032-1309819
Eliakim, 2013, Video capsule endoscopy of the small bowel, Curr Opin Gastroenterol, 29, 133, 10.1097/MOG.0b013e32835bdc03
Lemmens, 2013, Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitis, Inflamm Bowel Dis, 19, 1194, 10.1097/MIB.0b013e318280e75f
Feagins, 2013, Clinical implications of histologic abnormalities in colonic biopsy specimens from patients with ulcerative colitis in clinical remission, Inflamm Bowel Dis, 19, 1477, 10.1097/MIB.0b013e318281f4ae
Dignass, 2012, Second European evidence-based consensus on the diagnosis and management of ulcerative colitis. Part 1: definitions and diagnosis, J Crohns Colitis, 6, 965, 10.1016/j.crohns.2012.09.003
Seldenrijk, 1991, Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications, Gut, 32, 1514, 10.1136/gut.32.12.1514
Bentley, 2002, How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop, J Clin Pathol, 55, 955, 10.1136/jcp.55.12.955
Langner, 2014, The histopathological approach to inflammatory bowel disease: a practice guide, Virchows Arch, 464, 511
Magro, 2013, European consensus on the histopathology of inflammatory bowel disease, J Crohns Colitis, 7, 827, 10.1016/j.crohns.2013.06.001
Dignass, 2012, Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management, J Crohns Colitis, 6, 991, 10.1016/j.crohns.2012.09.002
Panes, 2013, Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines, J Crohns Colitis, 7, 556, 10.1016/j.crohns.2013.02.020
Deepak, 2014, Radiographical evaluation of ulcerative colitis, Gastroenterol Rep, 2, 169, 10.1093/gastro/gou026
Pola, 2012, Strategies for the care of adults hospitalized for active ulcerative colitis, Clin Gastroenterol Hepatol, 10, 10.1016/j.cgh.2012.07.006
Panes, 2017, Advances in use of endoscopy, radiology, and biomarkers to monitor inflammatory bowel diseases, Gastroenterology, 152, 10.1053/j.gastro.2016.10.005
Ordas, 2013, Diagnostic accuracy of magnetic resonance colonography for the evaluation of disease activity and severity in ulcerative colitis: a prospective study, Gut, 62, 1566, 10.1136/gutjnl-2012-303240
Oussalah, 2010, Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease, Gut, 59, 1056, 10.1136/gut.2009.197665
Baron, 1964, Variation between observers in describing mucosal appearances in proctocolitis, Br Med J, 1, 89, 10.1136/bmj.1.5375.89
Satsangi, 2006, The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications, Gut, 55, 749, 10.1136/gut.2005.082909
Schroeder, 1987, Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study, New Engl J Med, 317, 1625, 10.1056/NEJM198712243172603
Kornbluth, 2010, Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee, Am J Gastroenterol, 105, 501, 10.1038/ajg.2009.727
Peyrin-Biroulet, 2016, Defining disease severity in inflammatory bowel diseases: current and future directions, Clin Gastroenterol Hepatol, 14, 10.1016/j.cgh.2015.06.001
Higgins, 2005, Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis, Gut, 54, 782, 10.1136/gut.2004.056358
D'Haens, 2007, A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis, Gastroenterology, 132, 763, 10.1053/j.gastro.2006.12.038
D'Haens, 2007, A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis, Gastroenterology, 132, 763, 10.1053/j.gastro.2006.12.038
Shah, 2016, Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis, Clin Gastroenterol Hepatol, 14, 10.1016/j.cgh.2016.01.015
Gionchetti, 1998, Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis, Dis Colon Rectum, 41, 93, 10.1007/BF02236902
Pimpo, 2010, Mesalazine vanishing time from rectal mucosa following its topical administration, J Crohns Colitis, 4, 102, 10.1016/j.crohns.2009.08.003
Hanauer, 2000, Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis, Am J Gastroenterol, 95, 1749, 10.1111/j.1572-0241.2000.02185.x
Ford, 2011, Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis, Am J Gastroenterol, 106, 601, 10.1038/ajg.2011.67
Ford, 2012, Efficacy of oral vs. topical, or combined oral and topical 5-aminosalicylates, in ulcerative colitis: systematic review and meta-analysis, Am J Gastroenterol, 107, 167, 10.1038/ajg.2011.410
Marteau, 2005, Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study, Gut, 54, 960, 10.1136/gut.2004.060103
Sutherland, 2006, Oral 5‐aminosalicylic acid for maintenance of remission in ulcerative colitis, Cochrane Database Syst Rev
Safdi, 1997, A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis, Am J Gastroenterol, 92, 1867
Bressler, 2015, Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus, Gastroenterology, 148, 10.1053/j.gastro.2015.03.001
Feagan, 2012, Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis, Cochrane Database Syst Rev, 10, CD000543
Hanauer, 2005, Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial, Am J Gastroenterol, 100, 2478, 10.1111/j.1572-0241.2005.00248.x
Green, 2002, A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis, Aliment Pharmacol Ther, 16, 61, 10.1046/j.1365-2036.2002.01150.x
Giaffer, 1992, Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine, Aliment Pharmacol Ther, 6, 51, 10.1111/j.1365-2036.1992.tb00544.x
Rao, 1987, Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant of sulphasalazine, Scand J Gastroenterol, 22, 332, 10.3109/00365528709078600
Meyers, 1987, Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial, Gastroenterology, 93, 1255, 10.1016/0016-5085(87)90253-8
Sutherland, 2003, Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis, Cochrane Database Syst Rev, CD000543
Sandborn, 2015, Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis, Gastroenterology, 148, 10.1053/j.gastro.2015.01.037
Marshall, 1997, Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis, Gut, 40, 775, 10.1136/gut.40.6.775
Regueiro, 2006, Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials, Inflamm Bowel Dis, 12, 979, 10.1097/01.mib.0000231495.92013.5e
Mulder, 1996, Beclomethasone dipropionate (3 mg) versus 5-aminosalicylic acid (2 g) versus the combination of both (3 mg/2 g) as retention enemas in active ulcerative proctitis, Eur J Gastroenterol Hepatol, 8, 549, 10.1097/00042737-199606000-00010
Kamm, 2007, Once-daily, high-concentration MMX mesalamine in active ulcerative colitis, Gastroenterology, 132, 66, 10.1053/j.gastro.2006.10.011
Lichtenstein, 2007, Effect of once-or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis, Clin Gastroenterol Hepatol, 5, 95, 10.1016/j.cgh.2006.10.025
Harbord, 2017, Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management, J Crohns Colitis, 11, 769, 10.1093/ecco-jcc/jjx009
Danese, 2014, Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitis, Aliment Pharmacol Ther, 39, 1095, 10.1111/apt.12712
Sandborn, 2015, Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies, Aliment Pharmacol Ther, 41, 409, 10.1111/apt.13076
Travis, 2014, Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study, Gut, 63, 433, 10.1136/gutjnl-2012-304258
Truelove, 1962, Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis, Br Med J, 2, 1708, 10.1136/bmj.2.5321.1708
Regueiro, 2016, Established management paradigms in IBD: treatment targets and therapeutic tools, Am J Gastroenterol Suppl, 3, 8, 10.1038/ajgsup.2016.16
Jarnerot, 2005, Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study, Gastroenterology, 128, 1805, 10.1053/j.gastro.2005.03.003
Rutgeerts, 2005, Infliximab for induction and maintenance therapy for ulcerative colitis, New Engl J Med, 353, 2462, 10.1056/NEJMoa050516
Reinisch, 2011, Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial, Gut, 60, 780, 10.1136/gut.2010.221127
Sandborn, 2014, Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis, Gastroenterology, 146, 85, 10.1053/j.gastro.2013.05.048
Rutgeerts, 2005, Infliximab for induction and maintenance therapy for ulcerative colitis, New Engl J Med, 353, 2462, 10.1056/NEJMoa050516
Panaccione, 2014, Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis, Gastroenterology, 146, 10.1053/j.gastro.2013.10.052
Colombel, 2017, The safety of vedolizumab for ulcerative colitis and Crohn's disease, Gut, 66, 839, 10.1136/gutjnl-2015-311079
Feagan, 2013, Vedolizumab as induction and maintenance therapy for ulcerative colitis, New Engl J Med, 369, 699, 10.1056/NEJMoa1215734
Sandborn, 2017, Tofacitinib as induction and maintenance therapy for ulcerative colitis, New Engl J Med, 376, 1723, 10.1056/NEJMoa1606910
Sandborn, 2012, Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis, New Engl J Med, 367, 616, 10.1056/NEJMoa1112168
Pouillon, 2017, Tofacitinib is the right OCTAVE for ulcerative colitis, Gastroenterology, 153, 862, 10.1053/j.gastro.2017.07.027
Hsu, 2014, JAK inhibitors: treatment efficacy and safety profile in patients with psoriasis, J Immunol Res, 2014, 7, 10.1155/2014/283617
Carbonnel, 2016, Methotrexate is not superior to placebo for inducing steroid-free remission, but induces steroid-free clinical remission in a larger proportion of patients with ulcerative colitis, Gastroenterology, 150, 10.1053/j.gastro.2015.10.050
Sandborn, 2017, Tofacitinib as induction and maintenance therapy for ulcerative colitis, New Engl J Med, 376, 1723, 10.1056/NEJMoa1606910
Loftus, 2017, Long-term efficacy of vedolizumab for ulcerative colitis, J Crohns Colitis, 11, 400
Feagan, 2017, Efficacy of vedolizumab induction and maintenance therapy in patients with ulcerative colitis, regardless of prior exposure to tumor necrosis factor antagonists, Clin Gastroenterol Hepatol, 15, 10.1016/j.cgh.2016.08.044
Danese, 2014, Biological agents for moderately to severely active ulcerative colitis: a systematic review and network meta-analysis, Ann Intern Med, 160, 704, 10.7326/M13-2403
Järnerot, 1985, Intensive intravenous treatment of ulcerative colitis, Gastroenterology, 89, 1005, 10.1016/0016-5085(85)90201-X
van Dieren, 2008, Local application of tacrolimus in distal colitis: feasible and safe, Inflamm Bowel Dis, 15, 193, 10.1002/ibd.20644
Schmidt, 2013, Short‐term efficacy of tacrolimus in steroid‐refractory ulcerative colitis—experience in 130 patients, Aliment Pharmacol Ther, 37, 129, 10.1111/apt.12118
Sandborn, 1994, A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis, Gastroenterology, 106, 1429, 10.1016/0016-5085(94)90394-8
Lawrance, 2008, Rectal tacrolimus in the treatment of resistant ulcerative proctitis, Aliment Pharmacol Ther, 28, 1214, 10.1111/j.1365-2036.2008.03841.x
Bouguen, 2010, Infliximab for refractory ulcerative proctitis, Aliment Pharmacol Ther, 31, 1178, 10.1111/j.1365-2036.2010.04293.x
Brunel, 1999, Restorative proctocolectomy for distal ulcerative colitis, Gut, 45, 542, 10.1136/gut.45.4.542
Lynch, 2013, Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit, Aliment Pharmacol Ther, 38, 935, 10.1111/apt.12473
Van Assche, 2011, Management of acute severe ulcerative colitis, Gut, 60, 130, 10.1136/gut.2009.192765
Truelove, 1974, Intensive intravenous regimen for severe attacks of ulcerative colitis, Lancet, 303, 1067, 10.1016/S0140-6736(74)90552-2
Rosenberg, 1990, High-dose methylprednisolone in the treatment of active ulcerative colitis, J Clin Gastroenterol, 12, 40, 10.1097/00004836-199002000-00011
Turner, 2007, Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression, Clin Gastroenterol Hepatol, 5, 103, 10.1016/j.cgh.2006.09.033
Laharie, 2012, Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial, Lancet, 380, 1909, 10.1016/S0140-6736(12)61084-8
Duijvis, 2016, Similar short- and long-term colectomy rates with ciclosporin and infliximab treatment in hospitalised ulcerative colitis patients, J Crohns Colitis, 10, 821, 10.1093/ecco-jcc/jjw031
Kaplan, 2008, Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis, Gastroenterology, 134, 680, 10.1053/j.gastro.2008.01.004
Randall, 2010, Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications, Br J Surg, 97, 404, 10.1002/bjs.6874
Papadakis, 2001, Outcome of cytomegalovirus infections in patients with inflammatory bowel disease, Am J Gastroenterol, 96, 2137, 10.1111/j.1572-0241.2001.03949.x
Lynch, 2013, Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit, Aliment Pharmacol Ther, 38, 935, 10.1111/apt.12473
Kappelman, 2011, Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study, Gut, 60, 937, 10.1136/gut.2010.228585
McIntyre, 1986, Controlled trial of bowel rest in the treatment of severe acute colitis, Gut, 27, 481, 10.1136/gut.27.5.481
Dignass, 2015, European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases, J Crohns Colitis, 9, 211, 10.1093/ecco-jcc/jju009
Andersson, 2009, Surgery in ulcerative colitis: indication and timing, Dig Dis, 27, 335, 10.1159/000228570
Lichtenstein, 2006, Quality of life after proctocolectomy with ileoanal anastomosis for patients with ulcerative colitis, J Clin Gastroenterol, 40, 669, 10.1097/00004836-200609000-00002
Gajendran, 2018, Ileocecal anastomosis type significantly influences long-term functional status, quality of life, and healthcare utilization in postoperative Crohn's disease patients independent of inflammation recurrence, Am J Gastroenterol, 113, 576, 10.1038/ajg.2018.13
Kiran, 2010, Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience, Ann Surg, 252, 330, 10.1097/SLA.0b013e3181e61e69
Roberts, 2007, Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies, BMJ, 335, 1033, 10.1136/bmj.39345.714039.55
Carchman, 2016, Colorectal neoplasms: screening and surveillance after polypectomy, 417
Dayan, 2012, Role of surgery in severe ulcerative colitis in the era of medical rescue therapy, World J Gastroenterol, 18, 3833, 10.3748/wjg.v18.i29.3833
Travis, 2008, European evidence-based consensus on the management of ulcerative colitis: current management, J Crohns Colitis, 2, 24, 10.1016/j.crohns.2007.11.002
Lim, 2004, Emerging biologic therapies in inflammatory bowel disease, Rev Gastroenterol Disord, 4, 66
Ferrante, 2009, Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis, Inflamm Bowel Dis, 15, 1062, 10.1002/ibd.20863
Schluender, 2007, Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis?, Dis Colon Rectum, 50, 1747, 10.1007/s10350-007-9008-3
Selvasekar, 2007, Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis, J Am Coll Surg, 204, 956, 10.1016/j.jamcollsurg.2006.12.044
Mor, 2008, Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy, Dis Colon Rectum, 51, 1202, 10.1007/s10350-008-9364-7
Alves, 2003, Subtotal colectomy for severe acute colitis: a 20-year experience of a tertiary care center with an aggressive and early surgical policy, J Am Coll Surg, 197, 379, 10.1016/S1072-7515(03)00434-4
Pandey, 2011, Minimally invasive pouch surgery for ulcerative colitis: is there a benefit in staging?, Dis Colon Rectum, 54, 306, 10.1007/DCR.0b013e31820347b4
Grucela, 2009, Current surgical management of ulcerative colitis, Mt Sinai J Med, 76, 606, 10.1002/msj.20152
Krane, 2016, 869
Ware, 1992, The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection, Med Care, 30, 473, 10.1097/00005650-199206000-00002
Camilleri-Brennan, 2001, Objective assessment of quality of life following panproctocolectomy and ileostomy for ulcerative colitis, Ann R Coll Surg Engl, 83, 321
Ecker, 1996, Conversion of the failing ileoanal pouch to reservoir-ileostomy rather than to ileostomy alone, Dis Colon Rectum, 39, 977, 10.1007/BF02054684
Gelernt, 1977, The continent ileostomy in the pediatric patient, Hosp Pract, 12, 64, 10.1080/21548331.1977.11707113
da Luz Moreira, 2010, Clinical outcomes of ileorectal anastomosis for ulcerative colitis, Br J Surg, 97, 65, 10.1002/bjs.6809
Oakley, 1985, Complications and quality of life after ileorectal anastomosis for ulcerative colitis, Am J Surg, 149, 23, 10.1016/S0002-9610(85)80004-0
Leijonmarck, 1990, Long-term results of ileorectal anastomosis in ulcerative colitis in Stockholm County, Dis Colon Rectum, 33, 195, 10.1007/BF02134178
Pastore, 1997, Total abdominal colectomy and ileorectal anastomosis for inflammatory bowel disease, Dis Colon Rectum, 40, 1455, 10.1007/BF02070712
Kiran, 2014, Risk and location of cancer in patients with preoperative colitis-associated dysplasia undergoing proctocolectomy, Ann Surg, 259, 302, 10.1097/SLA.0b013e31828e7417
Gearhart, 2005, Sphincter defects are not associated with long-term incontinence following ileal pouch-anal anastomosis, Dis Colon Rectum, 48, 1410, 10.1007/s10350-004-0950-z
Sauer, 2003, Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94, Colorectal Dis, 5, 406, 10.1046/j.1463-1318.2003.00509.x
Kapiteijn, 1999, Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group, Eur J Surg, 165, 410, 10.1080/110241599750006613
Wu, 2013, Preoperative pelvic radiation increases the risk for ileal pouch failure in patients with colitis-associated colorectal cancer, J Crohns Colitis, 7, e419, 10.1016/j.crohns.2013.01.017
Canedo, 2010, Restorative proctectomy with ileal pouch-anal anastomosis in obese patients, Dis Colon Rectum, 53, 1030, 10.1007/DCR.0b013e3181db7029
Nicholls, 1987, Restorative proctocolectomy: the four loop (W) reservoir, Br J Surg, 74, 564, 10.1002/bjs.1800740705
Harms, 1992, The W ileal reservoir: long-term assessment after proctocolectomy for ulcerative colitis and familial polyposis, Surgery, 112, 638
Sagar, 1992, Comparison of triplicated (S) and quadruplicated (W) pelvic ileal reservoirs, Gastroenterology, 102, 520, 10.1016/0016-5085(92)90099-K
Miller, 1990, Improvement of anal sensation with preservation of the anal transition zone after ileoanal anastomosis for ulcerative colitis, Dis Colon Rectum, 33, 414, 10.1007/BF02156269
Fichera, 2007, Preservation of the anal transition zone in ulcerative colitis. Long-term effects on defecatory function, J Gastrointest Surg, 11, 1647, 10.1007/s11605-007-0321-x
Fazio, 1994, Transanal mucosectomy. Ileal pouch advancement for anorectal dysplasia or inflammation after restorative proctocolectomy, Dis Colon Rectum, 37, 1008, 10.1007/BF02049314
Lavery, 1995, Anal canal inflammation after ileal pouch-anal anastomosis. The need for treatment, Dis Colon Rectum, 38, 803, 10.1007/BF02049836
O'Connell, 1987, Does rectal mucosa regenerate after ileoanal anastomosis?, Dis Colon Rectum, 30, 1, 10.1007/BF02556908
O'Riordain, 2000, Incidence and natural history of dysplasia of the anal transitional zone after ileal pouch-anal anastomosis, Dis Colon Rectum, 43, 1660, 10.1007/BF02236846
Silvestri, 2008, Chronic inflammatory changes in the anal transition zone after stapled ileal pouch-anal anastomosis: is mucosectomy a superior alternative?, Surgery, 144, 533, 10.1016/j.surg.2008.06.003
Marchesa, 1997, The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis, Am J Gastroenterol, 92, 1285
Peyrin-Biroulet, 2016, Systematic review: outcomes and post-operative complications following colectomy for ulcerative colitis, Aliment Pharmacol Ther, 44, 807, 10.1111/apt.13763
de Silva, 2011, Postoperative complications and mortality following colectomy for ulcerative colitis, Clin Gastroenterol Hepatol, 9, 972, 10.1016/j.cgh.2011.07.016
Keswani, 2005, Postoperative management of ulcerative colitis and Crohn's disease, Curr Gastroenterol Rep, 7, 492, 10.1007/s11894-005-0081-2
Shen, 2005, Pouchitis: a spectrum of diseases, Curr Gastroenterol Rep, 7, 404, 10.1007/s11894-005-0011-3
Cheifetz, 2004, The diagnosis and treatment of pouchitis in inflammatory bowel disease, J Clin Gastroenterol, 38, S44, 10.1097/01.mcg.0000124001.93146.ef
Fazio, 2013, Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients, Ann Surg, 257, 679, 10.1097/SLA.0b013e31827d99a2
Lindsay, 2015, Systematic review: the financial burden of surgical complications in patients with ulcerative colitis, Aliment Pharmacol Ther, 41, 1066, 10.1111/apt.13197
Hata, 2017, Pouchitis after ileal pouch-anal anastomosis in ulcerative colitis: Diagnosis, management, risk factors, and incidence, Dig Endosc, 29, 26, 10.1111/den.12744
Mahadevan, 2003, Diagnosis and management of pouchitis, Gastroenterology, 124, 1636, 10.1016/S0016-5085(03)00325-1
Sandborn, 1994, Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index, Mayo Clin Proc, 69, 409, 10.1016/S0025-6196(12)61634-6
Sandborn, 1994, Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment, Gastroenterology, 107, 1856, 10.1016/0016-5085(94)90832-X
Shen, 2001, A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis, Inflamm Bowel Dis, 7, 301, 10.1097/00054725-200111000-00004
Gionchetti, 2000, Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial, Gastroenterology, 119, 305, 10.1053/gast.2000.9370
Mimura, 2004, Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis, Gut, 53, 108, 10.1136/gut.53.1.108
Shen, 2005, Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses, Am J Gastroenterol, 100, 93, 10.1111/j.1572-0241.2005.40778.x
Shen, 2004, Treatment of rectal cuff inflammation (cuffitis) in patients with ulcerative colitis following restorative proctocolectomy and ileal pouch-anal anastomosis, Am J Gastroenterol, 99, 1527, 10.1111/j.1572-0241.2004.30518.x
Parsi, 2004, Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis, Gastroenterology, 126, 1280, 10.1053/j.gastro.2004.02.012
Wagner-Bartak, 2005, Crohn's disease in the ileal pouch after total colectomy for ulcerative colitis: findings on pouch enemas in six patients, AJR Am J Roentgenol, 184, 1843, 10.2214/ajr.184.6.01841843
Viscido, 2003, Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis, Aliment Pharmacol Ther, 17, 1263, 10.1046/j.1365-2036.2003.01535.x